1. Disseminating Necrotizing Leukoencephalopathy Associated With Intra-CSF Methotrexate Chemotherapy, Neurology, March 12, 2024

2. Validation of the international MOGAD panel proposed criteria, Multiple sclerosis journal, Volume 29, Issue 13, November 2023

3. Reappraisal of CSF-specific oligoclonal band in Asia, Multiple sclerosis journal, Volume 28, Issue 4, April 2022

4. Seroprevalence of anti-myelin oligodendrocyte glycoprotein antibodies in adults with myelitis, Annals of clinical and translational neurology, Volume 9, Issue 9, September 2022

5. Onset of various CNS inflammatory demyelination diseases following COVID-19 vaccinations, Multiple sclerosis and related disorders, Volume 68, 104141, December 2022

6. Latent tubeculosis infection in Korean patients with multiple sclerosis and neuromyelitis optica spectrum disorder, Multiple sclerosis and related disorders, VOLUME 81, 105145, January 2024

7. Anti-titin antibody is associated with more frequent hospitalization to manage thymoma-associated myasthenia gravis, Frontiers in Neurology, Volume 13 - 2022

8. Real-world effectiveness of natalizumab in Korean patients with multiple sclerosis, Frontiers in Neurology, Frontiers in Neurology, Volume 12 - 2021

9. Initial repetitive nerve stimulation test predicts conversion of ocular myasthenia gravis to generalized myasthenia gravis, Journal of Clinical Neurology, 2021 Apr; 17(2): 265?272

10. Clinical and radiological features of myelin oligodendrocyte glycoprotein-associated myelitis in adults, Journal of Clinical Neurology, 2022 May; 18(3): 280?289

11. 성인 말이집희소돌기아교세포당단백질항체관련질환 환자 진료에 대한 권고합의안, J Mult Scler Neuroimmunol. 2023;14(2):87-98